On July 28, Northrop Grumman rose 3.18% in regular trading, trading at $558.07 per share with turnover of $121 million. The stock continues to benefit from a cluster of positive catalysts released in recent sessions.

The company reported Q2 EPS of $7.68, significantly beating the FactSet consensus estimate of $6.84. Revenue came in at $10.88 billion, also above the $10.80 billion estimate, while full-year sales guidance was raised to $43.75B-$44.25B. Net awards exceeded $20 billion with backlog reaching $105 billion. Additionally, the company secured a $1.2 billion U.S. Navy contract for production and delivery of three E-2D Advanced Hawkeye Block II aircraft, with completion expected by December 2031.

On the analyst front, Citigroup raised its price target to $617 from $587 maintaining a Buy rating, UBS lifted its target to $685 from $666, and Goldman Sachs modestly adjusted to $538 from $533. The broader defense sector exhibited strong momentum, with peers Lockheed Martin and RTX Corp surging 10% and 8% respectively following their own earnings beats, creating notable sector linkage effects.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)